c-Met (METor MNNG HOS Transforming gene) is a proto-oncogene that encodes a protein known as hepatocyte growth factor receptor (HGFR; RTK class X, HGF receptor family). It was originally identified as an oncogene activated in vitro after treatment of a human osteogenic sarcoma (HOS) cell line[1]. Currently, c-Met receives great interest for its role of aberrant signaling in tumorigenesis, particularly in the development of the invasive and metastatic phenotypes (see also Axon 2240). Signaling via the Met–HGF/SF pathway has been shown to lead to a wide range of biological activities including proliferation (mitosis), scattering (motility), and branching morphogenesis, embryological development, wound healing, tissue regeneration, angiogenesis, growth, invasion, and morphogenic differentiation[2].

[1] Molecular cloning of a new transforming gene from a chemically transformed human cell line. C.S. Cooper, M. Park, D.G. Blair et al. Nature 1984, 311, 29–33.
[2] M. Jeffers, L. Schmidt, N. Nakaigawa, et al. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA. 1997, 94, 11445–11450.


12 Item(s)

per page
Axon ID Name Description From price
1581 SU 11274 ATP-competitive inhibitor of c-MET €90.00
1914 SGX 523 ATP-competitive inhibitor of c-MET €120.00
1583 PF 04217903 mesylate c-MET tyrosine kinase Inhibitor €80.00
1660 PF 02341066 c-MET Inhibitor; NPM-ALK inhibitor €80.00
2553 LY 2801653 Orally bioavailable multi-kinase inhibitor with potent activity against c-MET €120.00
1959 Golvatinib Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2 €90.00
1582 Foretinib c-MET and VEGFR2 tyrosine kinase inhibitor €90.00
3423 Capmatinib Highly potent, selective, ATP competitive and orally bioavailable c-MET inhibitor €80.00
1819 Cabozantinib S-malate Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 €60.00
1838 ARQ 197 c-MET tyrosine kinase Inhibitor €90.00
2368 Amuvatinib RTK inhibitor which effectively inhibits PDGFR, c-Kit and c-Met €105.00
1916 AMG 208 Inhibitor of c-MET receptor tyrosine kinase (RTK) €95.00

12 Item(s)

per page
Please wait...